Pharmacists in Waynesville, North Carolina


29 Pharmacists found in Waynesville
male pharmacist

Mr. Jordan Thomas Gratton, PHARMD


Pharmacist
477 Hazelwood Ave, Waynesville, NC 28786
828-456-5112    

female pharmacist

Kaitlin Huff, PHARMD


Pharmacist
135 Town Center Loop, Waynesville, NC 28786
828-456-4828    

female pharmacist

Kimberly Bowen, PHARMD


Pharmacist
477 Hazelwood Ave, Waynesville, NC 28786
828-456-5112    



female pharmacist

Kimberly A Ferguson, RPH


Pharmacist
479 Dellwood Rd, Waynesville, NC 28786
828-452-2313     828-452-5451

female pharmacist

Kristie Woods Ball


Pharmacist
259 Barber Blvd, Waynesville, NC 28786
828-452-7455     828-452-7458

female pharmacist

Kristy Thompson, PHARMD


Pharmacist
477 Hazelwood Ave, Waynesville, NC 28786
828-456-5112    

female pharmacist

Laura Hall Ammons


Pharmacist
479 Dellwood Rd, Waynesville, NC 28786
828-452-2313     828-452-5451

female pharmacist

Dr. Lauren Keeler, PHARMD


Pharmacist
259 Barber Blvd, Waynesville, NC 28786
828-452-7455    

female pharmacist

Marianne Affinito


Pharmacist
135 Town Center Loop, Waynesville, NC 28786
828-452-1661    

female pharmacist

Michelle Davis, PHARMD


Pharmacist
479 Dellwood Rd, Waynesville, NC 28786
828-452-2313     828-452-5451

male pharmacist

Sridhar Reddy Enukonda


Pharmacist
590 Russ Ave, Waynesville, NC 28786
828-452-4211    

female pharmacist

Taylor Galyean, PHARMD


Pharmacist
590 Russ Ave, Waynesville, NC 28786
828-452-4211    

male pharmacist

Dr. William Henry Schnell, PHARM.D.


Pharmacist
773 Russ Ave, Waynesville, NC 28786
828-452-2230    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.